13. Percutaneous intervention for structural heart disease

TAVR: balloon-expandable vs self-expanding valves

CHOICE 5 years
Objective
to evaluate the 5-year clinical outcome of balloon-expandable versus self expanding valves for the percutaneous treatment of severe aortic valve stenosis
Study
investigator-initiated multicentre randomised trial
Population
patients with severe symptomatic aortic stenosis at high surgical risk
Endpoints
clinical outcomes at 5 years
Conclusion
there was no significant difference of clinical outcomes at 5-year follow-up between percutaneous treatment of aortic stenosis with balloon-expandable valve or self-expanding valves. However the statistical power of this study is low.
Abdel-Wahab et al. J Am Coll Cardiol Intv. 2020;13:1071-82
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved